The Impact of ¹²³I-Meta-Iodobenzylguanidine Scintigraphy on Diagnostics and Follow-up of Neuroblastoma

References

• Wieland D M, Wu J-I, Brown L E, Mangner T J, Swanson D P, Beierwaltes W H. Radiolabelled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzyl-guanidine. J Nucl Med 1980; 21: 349–53
   PubMed Web of Science ®Google Scholar
• Sisson J C, Frager M S, Valk T, et al. Scintigraphic localization of pheochromocytoma. New Engl J Med 1981; 305: 12–7
   PubMed Web of Science ®Google Scholar
• Kimmig B, Brandeis W E, Eisenhut M, Bubeck B, Hermann H J, Winkel K zum. Scintigraphy of a neuroblastoma with I-131 meta-iodobenzylguanidine. J Nucl Med 1984; 25: 773–5
   PubMed Web of Science ®Google Scholar
• Geatti O, Shapiro B, Sisson J C, et al. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases. J Nucl Med 1985; 26: 736–42
   PubMed Web of Science ®Google Scholar
• Hoefnagel C A, Voüte P A, de Kraker J, Marcuse H R. Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma. Diag Imag Clin Med 1985; 54: 21–7
   PubMedGoogle Scholar
• Bomanji J, Levison D A, Flatman W D, et al. Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison. J Nucl Med 1987; 28: 973–8
   PubMed Web of Science ®Google Scholar
• Troncone L, Rufini V, Montemaggi P, Danza F M, Lasorella A, Mastrangelo R. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). Eur J Nucl Med 1990; 16: 325–35
   PubMedGoogle Scholar
• Hoefnagel C A, Voûte P A, de Kraker J, Marcuse H R. Radionuclide diagnosis and therapy of neural crest tumours using iodine-131 metaiodobenzylguanidine. J Nucl Med 1987; 28: 308–14
   PubMed Web of Science ®Google Scholar
• Hoefnagel C A, de Kraker J, Voûte P A, Olmos R AV. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis (“MIBG de novo”). J Nucl Biol Med 1991; 35: 248–51
   PubMedGoogle Scholar
• Carlsen N LT. Neuroblastoma: epidemiology and pattern of regression. Am J Ped Hematol Oncol 1992; 14: 103–10
   PubMedGoogle Scholar
• Schmiegelow K, Siimes M A, Agertoft L, et al. Radioiodobenzylguanidine scintigraphy of neuroblastoma: conflicting results, when compared with standard investigations. Med Pediatr Oncol 1989; 17: 126–30
   Google Scholar
• Solanki K K, Bomanhi J, Moyes J, Mather S J, Trainer P J, Britton K E. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled metaiodobenzylguanidine. Nucl Med Commun 1992; 13: 513–21
   PubMed Web of Science ®Google Scholar
• Gelfand M J. Meta-iodobenzylguanidine in children. Semin Nucl Med 1993; 23: 231–242
   PubMedGoogle Scholar
• Guertner C, Klepzig H, Maul F D, et al. Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomography. Eur J Nucl Med 1993; 20: 776–82
   PubMedGoogle Scholar
• Shakespeare C F, Page C J, O'Doherty M J, et al. Regional sympathetic innervation of the heart by means of metaiodobenzylguanidine imaging in silent ischemia. Am Heart J 1993; 125: 1614–21
   PubMed Web of Science ®Google Scholar
• Bouvier J F, Philip T, Chauvot P, et al. Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases. Prog Clin Biol Res 1988; 271: 707–20
   PubMedGoogle Scholar
• Shulkin B L, Shapiro B, Hutchinson R J. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma. J Nucl Med 1992; 33: 1735–40
   PubMed Web of Science ®Google Scholar
• Young G, L'Heureux P. Extraosseus tumour uptake of 99m technetium phosphate compounds in children with abdominal neurobastoma. Pediat Radiol 1978; 7: 159–63
   PubMed Web of Science ®Google Scholar
• Smith F W, Gilday D L, Ash J M, Reid R H. Primary neuroblastoma uptake of 99m technetium methylene diphosphonate. Radiology 1980; 137: 501–3
   PubMed Web of Science ®Google Scholar
• Merten D F, Kirks D R. Diagnostic imaging of paediatric abdominal masses. Pediatrics Clin N.A. 1985; 32: 1397–425
   PubMed Web of Science ®Google Scholar
• Pizzo P A, Horowitz M E, Poplack D G, Hays D M, Kun L E. Solid tumours of childhood. Cancer: principles & practice of oncology, V T DeVita, S Hellman, S A Rosenberg. JB Lippincott Co, Philadelphia 1993; 1749–55
   Google Scholar
• Heisel M A, Miller J H, Reid B S, Siegel S E. Radionuclide bone scan in neuroblastoma. Pediatrics 1983; 71: 206–9
   PubMed Web of Science ®Google Scholar
• Daubenton J D, Fisher R M, Karabus C D, Mann M D. The relationship between prognosis and scintigraphic evidence of bone metastases in neuroblastoma. Cancer 1987; 59: 1586–9
   PubMed Web of Science ®Google Scholar
• Gordon I, Peters A M, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. Skeletal assessment in neuroblastoma—the pitfalls of iodine-123-MIBG scans. J Nucl Med 1990; 31: 129–34
   PubMed Web of Science ®Google Scholar
• Maris J M, Evans A E, McLaughlin A C, et al. 31P Nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. New Engl J Med 1985; 312: 1500–5
   PubMed Web of Science ®Google Scholar
• Yeh S DJ, Larson S M, Burch L, et al. Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities. J Nucl Med 1991; 32: 769–76
   PubMed Web of Science ®Google Scholar
• Corbett R, Fullbrook A., Meller S, Flower M. 123Iodine meta-iodobenzylguanidine single photon emission computed tomography in the assessment of children with neuroblastoma. Prog Clin Biol Res 1991; 366: 479–85
   PubMedGoogle Scholar
• Oei H Y, Krenning E P, Lamberts S WJ. Somatostatin receptor imaging using octreoscan In 111. Mallinckrodt Medical BV Publication, PettenThe Netherlands 1991
   Google Scholar
• Sawada T, Sugimoto T, Tanaka T, et al. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects. Med Pediatr Oncol 1987; 15: 14–7
   PubMedGoogle Scholar
• Sawada T, Nagahara N, Yamamoto K, et al. Mass screening for neuroblastoma in Japan. Acta Paediatr Jpn 1990; 32: 725–33
   PubMedGoogle Scholar
• Tuchman M, Lemieux B, Auray-Blais C, et al. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec neuroblastoma screening project. Pediatrics 1990; 86: 765–73
   PubMed Web of Science ®Google Scholar
• Jacobs A, Delree M, Desprechins B, et al. Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol 1990; 20: 157–9
   PubMed Web of Science ®Google Scholar
• Moyes J, McCready V R, Fullbrook A. Neuroblastoma, MIBG in its diagnosis and management. Springer-Verlag, Berlin, Heidelberg 1989
   Google Scholar
• Parisi M T, Greene M K, Dykes T M, Moraldo T V, Sandler E D, Hattner R S. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma. Invest Radiol 1992; 27: 768–73
   PubMed Web of Science ®Google Scholar
• Evans A E. Staging and treatment of neuroblastoma. Cancer 1980; 45: 1799–802
   PubMed Web of Science ®Google Scholar